Impact of peripheral arterial disease on health status: A comparison with chronic heart failure

Journal of Vascular Surgery

Volumn 50, Issue 6, 2009, Pages 1391-1398

  Smolderen, Kim G ^a   Pelle, Aline J ^a   Kupper, Nina ^a   Mols, Floortje ^a   Denollet, Johan ^a  

^a TILBURG UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE SEVERITY; EDUCATIONAL STATUS; EFFECT SIZE; FEMALE; HEALTH STATUS; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL HEALTH; NETHERLANDS; OBSERVATIONAL STUDY; OUTPATIENT; OUTPATIENT DEPARTMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SHORT FORM 12; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGE FACTORS; AGED; AMBULATORY CARE FACILITIES; CHRONIC DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EDUCATIONAL STATUS; FEMALE; HEART DISEASES; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MARITAL STATUS; MENTAL HEALTH; MIDDLE AGED; NETHERLANDS; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PROPENSITY SCORE; RISK ASSESSMENT; RISK FACTORS; SICKNESS IMPACT PROFILE;

EID: 70549085990     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.07.109     Document Type: Article

References (34)

1. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 Suppl 1 (2007) S1-S75
2. McDermott M.M., Hahn E.A., Greenland P., Cella D., Ockene J.K., Brogan D., et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med 17 (2002) 895-904
3. Welten G.M., Schouten O., Hoeks S.E., Chonchol M., Vidakovic R., van Domburg R.T., et al. Long-term prognosis of patients with peripheral arterial disease: a comparison in patients with coronary artery disease. J Am Coll Cardiol 51 (2008) 1588-1596
4. Hirsch A.T., Gloviczki P., Drooz A., Lovell M., and Creager M.A. Mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 39 (2004) 474-481
5. Dumville J.C., Lee A.J., Smith F.B., and Fowkes F.G. The health-related quality of life of people with peripheral arterial disease in the community: the Edinburgh Artery Study. Br J Gen Pract 54 (2004) 826-831
6. Safley D.M., House J.A., Laster S.B., Daniel W.C., Spertus J.A., and Marso S.P. Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation 115 (2007) 569-575
7. Krumholz H.M., Peterson E.D., Ayanian J.Z., Chin M.H., DeBusk R.F., Goldman L., et al. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 111 (2005) 3158-3166
8. Stanek E.J., Oates M.B., McGhan W.F., Denofrio D., and Loh E. Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail 6 (2000) 225-232
9. Clark A.M., Hartling L., Vandermeer B., and McAlister F.A. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 143 (2005) 659-672
10. Hobbs F.D., Kenkre J.E., Roalfe A.K., Davis R.C., Hare R., and Davies M.K. Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. Eur Heart J 23 (2002) 1867-1876
11. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
12. Ware Jr. J., Kosinski M., and Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34 (1996) 220-233
13. Gandek B., Ware J.E., Aaronson N.K., Apolone G., Bjorner J.B., Brazier J.E., et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 51 (1998) 1171-1178
14. Ware Jr. J.E., Kosinski M., Bayliss M.S., McHorney C.A., Rogers W.H., and Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33 (1995) AS264-AS279
15. Mols F., Pelle A.J., and Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the Dutch population. Qual Life Res 18 (2009) 403-414
16. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
17. Cohen J. Statistical power analysis for the behavioral sciences (1988), Erlbaum, Hillsdale, NJ
18. Rumsfeld J.S., Magid D.J., Plomondon M.E., Sales A.E., Grunwald G.K., Every N.R., et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J 145 (2003) 493-499
19. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
20. Conroy R.M., Pyorala K., Fitzgerald A.P., Sans S., Menotti A., De Backer G., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24 (2003) 987-1003
21. Walke L.M., Gallo W.T., Tinetti M.E., and Fried T.R. The burden of symptoms among community-dwelling older persons with advanced chronic disease. Arch Intern Med 164 (2004) 2321-2324
22. Regensteiner J.G., Hiatt W.R., Coll J.R., Criqui M.H., Treat-Jacobson D., McDermott M.M., et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 13 (2008) 15-24
23. Smolderen K.G., Aquarius A.E., de Vries J., Smith O.R., Hamming J.F., and Denollet J. Depressive symptoms in peripheral arterial disease: A follow-up study on prevalence, stability, and risk factors. J Affect Disord 110 (2008) 27-35
24. Cherr G., Zimmerman P., Wang J., and Dosluoglu H. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization. J Gen Intern Med 23 (2008) 629-634
25. Stromberg A., and Jaarsma T. Thoughts about death and perceived health status in elderly patients with heart failure. Eur J Heart Fail 10 (2008) 608-613
26. Levenson J.W., McCarthy E.P., Lynn J., Davis R.B., and Phillips R.S. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 48 (2000) S101-S109
27. Bernheim S.M., Spertus J.A., Reid K.J., Bradley E.H., Desai R.A., Peterson E.D., et al. Socioeconomic disparities in outcomes after acute myocardial infarction. Am Heart J 153 (2007) 313-319
28. Ting H.H., Bradley E.H., Wang Y., Lichtman J.H., Nallamothu B.K., Sullivan M.D., et al. Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med 168 (2008) 959-968
29. Kasper E.K., Gerstenblith G., Hefter G., Van Anden E., Brinker J.A., Thiemann D.R., et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol 39 (2002) 471-480
30. Whellan D.J., Gaulden L., Gattis W.A., Granger B., Russell S.D., Blazing M.A., et al. The benefit of implementing a heart failure disease management program. Arch Intern Med 161 (2001) 2223-2228
31. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 28 (2007) 2375-2414
32. Aquarius A.E., De Vries J., Henegouwen D.P., and Hamming J.F. Clinical indicators and psychosocial aspects in peripheral arterial disease. Arch Surg 141 (2006) 161-166 discussion 166
33. Aquarius A.E., Denollet J., de Vries J., and Hamming J.F. Poor health-related quality of life in patients with peripheral arterial disease: Type D personality and severity of peripheral arterial disease as independent predictors. J Vasc Surg 46 (2007) 507-512
34. Heidenreich P.A., Spertus J.A., Jones P.G., Weintraub W.S., Rumsfeld J.S., Rathore S.S., et al. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 47 (2006) 752-756